Abstract: An exercise apparatus comprising two adjustable cuffs configured to encircle a user's extremity on either side of an articulated joint, such as the elbow. Each cuff is provided with a connector ring for conveniently connecting a pull line to a weight machine, suspended free weight, or other resistance generating exercise machine. One or both connector rings may be engaged by the pull line. The two connector rings are interconnected by an adjustable-length isolator strap which limits the range of motion of the user's elbow. By isolating arm movement, the apparatus enables isolated exercise of chest, shoulder, or back muscle groups. As hands are not necessary, the apparatus also enables users having a hand or other lower arm infirmity to continue other upper-body muscle exercises.

Abstract: An exercise apparatus comprising two adjustable cuffs configured to encircle a user's extremity on either side of an articulated joint, such as the elbow. Each cuff is provided with a connector ring for conveniently connecting a pull line to a weight machine, suspended free weight, or other resistance generating exercise machine. One or both connector rings may be engaged by the pull line. The two connector rings are interconnected by an adjustable-length isolator strap which omits the range of motion of the user's elbow. By isolating arm movement, the apparatus enables isolated exercise of chest, shoulder, or back muscle groups. As hands are not necessary, the apparatus also enables users having a hand or other lower arm infirmity to continue other upper-body muscle exercises.

Abstract: A method for treating neoplastic, angiogenic, vascular, fibroblastic, immunosuppressive, infectious, metabolic, and/or constitutional irregularities of the eye and/or joint of a living subject, comprising the steps of: providing a living subject, wherein the living subject includes an affected ocular and/or joint area having a neoplastic, angiogenic, fibroblastic, immunosuppressive, infectious, metabolic, and/or constitutional irregularity; providing a combretastatin-A4 based medicament, wherein the combretastatin-A4 based medicament is capable of preventing microtubule assembly, inhibiting the proliferation of endothelial, eukaryotic, and neoplastic cells, or altering their shape and function, as well as providing an anti-inflammatory effect; associating a therapeutically effective concentration of the combretastatin based medicament with the affected ocular and/or joint area of the living subject; and decreasing the neoplastic, angiogenic, vascular, fibroblastic, immunosuppressive, infectious, metabolic and